
Gydro M 80mg/250mg Tablet
Marketer
Norden Lifesciences
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Gydro M 80mg/250mg Tablet
Abdominal pain is effectively managed by the combined action of the components within Gydro M 80mg/250mg Tablets. This medication alleviates abdominal pain, bloating, discomfort, and cramping by inducing relaxation in the stomach and intestinal muscles. Simultaneously, it inhibits specific chemical signals responsible for pain and discomfort. Gydro M 80mg/250mg Tablets should be taken with food, following the dosage and duration prescribed by your physician. Dosage is tailored to individual needs and response. Consistent use, as directed by your doctor, is crucial; premature discontinuation may lead to symptom recurrence and potential worsening of your condition. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects, such as diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn, are often temporary and self-limiting. However, report any concerns to your doctor promptly. Dizziness and drowsiness may occur; refrain from driving or activities requiring concentration until the effects are known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Before initiating treatment, discuss your pregnancy status (including planning or breastfeeding) and any existing kidney or liver conditions with your physician to ensure appropriate dosage selection.
Uses of Gydro M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Gydro M 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. The Gydro M 80mg/250mg Tablet should be administered with a meal.
Common Side effects of Gydro M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Gydro M 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire Gydro M 80mg/250mg tablet without crushing, chewing, or breaking it. Administer this medication with a meal.
How Gydro M 80mg/250mg Tablet works:
Gydro M 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-inducing chemicals in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gydro M 80mg/250mg Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Gydro M 80mg/250mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Gydro M 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Gydro M 80mg/250mg tablets might lead to adverse reactions, potentially impairing driving ability due to the possibility of dizziness.
KidneyCAUTION
Patients with kidney impairment should use Gydro M 80mg/250mg Tablets cautiously, potentially requiring dosage modification. Consult your physician. Gydro M 80mg/250mg Tablets are contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Gydro M 80mg/250mg tablets cautiously. Dosage modification of Gydro M 80mg/250mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Gydro M 80mg/250mg Tablet :
Should you forget a Gydro M 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gydro M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
